$MYSZ
My Size, Inc.

2024 Q3 Form 10-Q Financial Statement

#000149315224031274 Filed on August 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $1.839M $1.979M
YoY Change -14.7% 53.41%
Cost Of Revenue $1.048M $995.0K
YoY Change 34.36% 29.05%
Gross Profit $791.0K $984.0K
YoY Change -42.51% 89.6%
Gross Profit Margin 43.01% 49.72%
Selling, General & Admin $1.377M $1.730M
YoY Change -38.5% -6.28%
% of Gross Profit 174.08% 175.81%
Research & Development $89.00K $131.0K
YoY Change -63.22% -42.29%
% of Gross Profit 11.25% 13.31%
Depreciation & Amortization $168.0K $8.000K
YoY Change 95.35% -88.57%
% of Gross Profit 21.24% 0.81%
Operating Expenses $2.097M $1.861M
YoY Change -15.48% -10.23%
Operating Profit -$1.306M -$877.0K
YoY Change 18.19% -43.56%
Interest Expense $6.000K -$87.00K
YoY Change -53.85% -317.5%
% of Operating Profit
Other Income/Expense, Net $6.000K -$87.00K
YoY Change -72.73% -289.13%
Pretax Income -$1.300M -$964.0K
YoY Change 19.05% -36.29%
Income Tax
% Of Pretax Income
Net Earnings -$1.300M -$964.0K
YoY Change 14.84% -25.33%
Net Earnings / Revenue -70.69% -48.71%
Basic Earnings Per Share -$1.25 -$1.28
Diluted Earnings Per Share -$1.25 -$1.28
COMMON SHARES
Basic Shares Outstanding 1.067M shares 641.5K shares
Diluted Shares Outstanding 1.040M shares 755.6K shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.371M $3.201M
YoY Change -35.83% 183.27%
Cash & Equivalents $2.371M $3.201M
Short-Term Investments
Other Short-Term Assets $0.00 $74.00K
YoY Change -100.0% -38.33%
Inventory $2.238M $1.793M
Prepaid Expenses
Receivables $327.0K $329.0K
Other Receivables $1.013M $807.0K
Total Short-Term Assets $5.949M $6.204M
YoY Change -26.28% 55.41%
LONG-TERM ASSETS
Property, Plant & Equipment $66.00K $107.0K
YoY Change -41.07% -17.69%
Goodwill $131.0K $733.0K
YoY Change -90.65% -47.75%
Intangibles $845.0K $919.0K
YoY Change -26.46% -25.16%
Long-Term Investments $7.000K $10.00K
YoY Change -90.41% -87.5%
Other Assets $7.000K $7.000K
YoY Change -73.08% -76.67%
Total Long-Term Assets $1.083M $1.808M
YoY Change -65.43% -45.25%
TOTAL ASSETS
Total Short-Term Assets $5.949M $6.204M
Total Long-Term Assets $1.083M $1.808M
Total Assets $7.032M $8.012M
YoY Change -37.23% 9.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.329M $896.0K
YoY Change -49.22% -41.44%
Accrued Expenses $16.00K $17.00K
YoY Change -88.32% -88.67%
Deferred Revenue
YoY Change
Short-Term Debt $123.0K $423.0K
YoY Change -46.52% 178.29%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.385M $2.109M
YoY Change -47.85% -32.12%
LONG-TERM LIABILITIES
Long-Term Debt $177.0K $193.0K
YoY Change -33.96% -36.93%
Other Long-Term Liabilities $12.00K $15.00K
YoY Change -92.31% -92.5%
Total Long-Term Liabilities $189.0K $208.0K
YoY Change -72.92% -72.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.385M $2.109M
Total Long-Term Liabilities $189.0K $208.0K
Total Liabilities $2.574M $2.317M
YoY Change -51.17% -39.99%
SHAREHOLDERS EQUITY
Retained Earnings -$63.16M -$61.86M
YoY Change 7.82% 7.69%
Common Stock $1.000K $1.000K
YoY Change -66.67% -50.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.458M $5.695M
YoY Change
Total Liabilities & Shareholders Equity $7.032M $8.012M
YoY Change -37.23% 9.84%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$1.300M -$964.0K
YoY Change 14.84% -25.33%
Depreciation, Depletion And Amortization $168.0K $8.000K
YoY Change 95.35% -88.57%
Cash From Operating Activities -$447.0K -$659.0K
YoY Change -64.8% -50.45%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -335.0K 2.554M
YoY Change -109.22% -8613.33%
NET CHANGE
Cash From Operating Activities -447.0K -659.0K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities -335.0K 2.554M
Net Change In Cash -782.0K 1.895M
YoY Change -133.08% -239.34%
FREE CASH FLOW
Cash From Operating Activities -$447.0K -$659.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
131000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1933000 usd
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
74000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-870000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61861000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
5695000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8012000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4963000 usd
CY2024Q2 MYSZ Sort Term Deposit
SortTermDeposit
usd
MYSZ Equity Loss Of Equity Method Investees
EquityLossOfEquityMethodInvestees
usd
CY2024Q2 MYSZ Equity Loss Of Equity Method Investees
EquityLossOfEquityMethodInvestees
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
MYSZ Stock Issued During Period Value Effect Of Reverse Stock Splits
StockIssuedDuringPeriodValueEffectOfReverseStockSplits
usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
CY2024Q2 MYSZ Stock Issued During Period Value Effect Of Reverse Stock Splits
StockIssuedDuringPeriodValueEffectOfReverseStockSplits
usd
CY2024Q2 MYSZ Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
usd
MYSZ Increase Decrease In Investment In Joint Venture
IncreaseDecreaseInInvestmentInJointVenture
usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
usd
us-gaap Proceeds From Hedge Investing Activities
ProceedsFromHedgeInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
usd
MYSZ Change In Operating Lease Rightofuse Asset And Liability
ChangeInOperatingLeaseRightofuseAssetAndLiability
usd
CY2023Q4 MYSZ Sort Term Deposit
SortTermDeposit
22000 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
883131 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
883131 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
452724 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
452724 shares
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
68425000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
65386000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-771000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59881000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4735000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8991000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2010000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1979000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1290000 usd
us-gaap Cost Of Revenue
CostOfRevenue
2783000 usd
us-gaap Cost Of Revenue
CostOfRevenue
1918000 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
995000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
771000 usd
us-gaap Gross Profit
GrossProfit
2180000 usd
us-gaap Gross Profit
GrossProfit
92000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
984000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
519000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
263000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
569000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
227000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1646000 usd
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
831000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
967000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1932000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1923000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
899000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
879000 usd
us-gaap Operating Expenses
OperatingExpenses
4128000 usd
us-gaap Operating Expenses
OperatingExpenses
4138000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
1861000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
2073000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1948000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4046000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-877000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1554000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-32000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-100000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-87000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
46000 usd
MYSZ Equity Loss Of Equity Method Investees
EquityLossOfEquityMethodInvestees
39000 usd
CY2023Q2 MYSZ Equity Loss Of Equity Method Investees
EquityLossOfEquityMethodInvestees
5000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1980000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4185000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-964000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1513000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-240000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-222000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1980000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3945000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-964000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1291000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-99000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-39000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
8000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-24000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2079000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3984000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-956000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1315000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-14.40
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-14.40
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.28
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.28
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.24
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.24
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
647321 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
647321 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
273845 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
273845 shares
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
755600 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
755600 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
305519 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
305519 shares
us-gaap Inventory Write Down
InventoryWriteDown
643000 usd
CY2024Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1:8 reverse stock split
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4735000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
217000 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
3000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
442000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2819000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2079000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
5695000 usd
CY2024Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1:8 reverse stock split
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4536000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
222000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
341000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2658000 usd
MYSZ Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
1000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3984000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3433000 usd
CY2024Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1:8 reverse stock split
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
3753000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
79000 usd
CY2024Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
442000 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2819000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-956000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
5695000 usd
CY2024Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1:8 reverse stock split
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
4662000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
86000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1315000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3433000 usd
CY2024Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1:8 reverse stock split
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4536000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4536000 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
453000 usd
CY2023 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
959000 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6258000 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6258000 usd
CY2023 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
2000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6514000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4735000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4735000 usd
CY2024Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1:8 reverse stock split
us-gaap Net Income Loss
NetIncomeLoss
-1980000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3945000 usd
us-gaap Depreciation
Depreciation
16000 usd
us-gaap Depreciation
Depreciation
16000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
138000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
88000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
76000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
151000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-525000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-76000 usd
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
41000 usd
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
11000 usd
us-gaap Interest Paid
InterestPaid
37000 usd
us-gaap Interest Paid
InterestPaid
11000 usd
MYSZ Revaluation Of Investment In Marketable Securities
RevaluationOfInvestmentInMarketableSecurities
4000 usd
MYSZ Revaluation Of Investment In Marketable Securities
RevaluationOfInvestmentInMarketableSecurities
-23000 usd
MYSZ Increase Decrease In Investment In Joint Venture
IncreaseDecreaseInInvestmentInJointVenture
39000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
217000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
222000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1080000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
95000 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-36000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-282000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1119000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-97000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-68000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-38000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
205000 usd
MYSZ Increase Decrease In Trade Payable
IncreaseDecreaseInTradePayable
-1212000 usd
MYSZ Increase Decrease In Trade Payable
IncreaseDecreaseInTradePayable
-888000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-109000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
15000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2076000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3640000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
38000 usd
us-gaap Proceeds From Hedge Investing Activities
ProceedsFromHedgeInvestingActivities
22000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
60000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2819000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2658000 usd
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
500000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
358000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
62000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2961000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2596000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
66000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-69000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1011000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1113000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2264000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2363000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3275000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1250000 usd
MYSZ Change In Operating Lease Rightofuse Asset And Liability
ChangeInOperatingLeaseRightofuseAssetAndLiability
181000 usd
CY2024Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1014000 usd
CY2024Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
3000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61861000 usd
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
4000 usd
CY2024Q2 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
21000 usd
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
1000 usd
CY2023Q2 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
7000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
220000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
222000 usd
CY2024Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
79000 usd
CY2023Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
86000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
(i) 5,000 shares of restricted common stock of the Company, (ii) a warrant to purchase 12,500 shares of common stock at an exercise price of $4.00 per share and exercisable for a term of 36 months from the date of issuance, and (iii) a warrant to purchase 12,500 shares of common stock at an exercise price of $6.00 per share and exercisable for a term of 36 months from the date of issuance
CY2024Q2 us-gaap Goodwill
Goodwill
733000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
1403000 usd
CY2023Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2023Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q4 us-gaap Sale Of Stock Description Of Transaction
SaleOfStockDescriptionOfTransaction
The Notification Letter provided that the Company had 180 calendar days, or until May 1, 2024, to regain compliance with the Rule. To regain compliance, the bid price of the Company’s common stock must have had a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. On May 7, 2024, the Company received a letter from Nasdaq that, for the 10 consecutive business days from April 23, 2024 to May 6, 2024, the closing bid price of the Company’s common stock had been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and Nasdaq considers the prior bid price deficiency matter now closed
CY2024Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3260000 usd
CY2024Q2 us-gaap Shares Issued
SharesIssued
166989 shares
CY2024Q2 MYSZ Cash Fee Percentage
CashFeePercentage
0.070 pure
CY2024Q2 MYSZ Management Fee Percentage
ManagementFeePercentage
0.010 pure
CY2024Q2 MYSZ Cash Fee Percentage
CashFeePercentage
0.070 pure
CY2024Q2 MYSZ Management Fee Percentage
ManagementFeePercentage
0.010 pure
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
46969 shares
CY2024Q2 MYSZ Cash Fee Percentage
CashFeePercentage
0.070 pure
CY2024Q2 MYSZ Fee Percentage
FeePercentage
1.25 pure
CY2024Q2 us-gaap Other Expenses
OtherExpenses
85000 usd
CY2024Q2 us-gaap Clearance Fees
ClearanceFees
16000 usd
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001493152-24-031274-index-headers.html Edgar Link pending
0001493152-24-031274-index.html Edgar Link pending
0001493152-24-031274.txt Edgar Link pending
0001493152-24-031274-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
mysz-20240630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
mysz-20240630_cal.xml Edgar Link unprocessable
mysz-20240630_def.xml Edgar Link unprocessable
mysz-20240630_lab.xml Edgar Link unprocessable
mysz-20240630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
Show.js Edgar Link pending